↓ Skip to main content
What is this page? Embed badge

A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease

Overview of attention for article published in Kidney International, August 2024
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 X users
facebook
1 Facebook page
guideline
1 clinical guideline source
bluesky
2 Bluesky users

Readers on

mendeley
110 Mendeley